Teachers Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Teachers Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,787	Closed	-$72K	–	3105
2018 Q1	$72K	Hold	6,787	–	–	﹤0.01%	2956
2017 Q4	$286K	Buy	6,787 +86	+1%	+$3.86K	﹤0.01%	2819
2017 Q3	$369K	Sell	6,701 -63	-0.9%	-$10.6K	﹤0.01%	2724
2017 Q2	$1.25M	Buy	6,764 +1,601	+31%	+$281K	﹤0.01%	2100
2017 Q1	$617K	Hold	5,163	–	–	﹤0.01%	2427
2016 Q4	$513K	Buy	5,163 +255	+5%	+$26.9K	﹤0.01%	2527
2016 Q3	$550K	Hold	4,908	–	–	﹤0.01%	2428
2016 Q2	$504K	Buy	4,908 +2,227	+83%	+$223K	﹤0.01%	2406
2016 Q1	$246K	Hold	2,681	–	–	﹤0.01%	2713
2015 Q4	$387K	Buy	2,681 +887	+49%	+$115K	﹤0.01%	2552
2015 Q3	$185K	Buy	+1,794	New	+$210K	﹤0.01%	2899

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Teachers Advisors's SIOX Position: Q2 2018 in Review

Teachers Advisors sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 6,787 shares — an estimated $72K sold.

Teachers Advisors first reported a position in SIOX in Q3 2015 and held it in 11 quarters. The position peaked at $1.25M in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

Teachers Advisors reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Teachers Advisors sold 6,787 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $72K.
Teachers Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 11 quarters.
Teachers Advisors's Sio Gene Therapies Inc. Common Stock position peaked at $1.25M in Q2 2017.
71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.